Try our Advanced Search for more refined results
April 23, 2009
Pronova BioPharma Norge AS v. Teva Pharamceuticals USA, Inc.
Case Number:
1:09-cv-00286
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 29, 2012
Pronova Defeats Teva, Par In Lovaza Patent Suit
A Delaware federal judge ruled Tuesday that Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Inc. infringed two Pronova Biopharma Norge AS patents when they filed applications to sell a generic version of triglyceride-lowering drug Lovaza in 2009.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login